{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T22:59:16Z","timestamp":1770332356517,"version":"3.49.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T00:00:00Z","timestamp":1641254400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T00:00:00Z","timestamp":1641254400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"national institute of neurological disorders and stroke","doi-asserted-by":"publisher","award":["1R01NS094041"],"award-info":[{"award-number":["1R01NS094041"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000061","name":"fogarty international center","doi-asserted-by":"publisher","award":["K43TW011583"],"award-info":[{"award-number":["K43TW011583"]}],"id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"national heart, lung, and blood institute","doi-asserted-by":"publisher","award":["1K24 HL148305"],"award-info":[{"award-number":["1K24 HL148305"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"national heart, lung, and blood institute","doi-asserted-by":"publisher","award":["5U24HL136790"],"award-info":[{"award-number":["5U24HL136790"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"national center for advancing translational sciences","doi-asserted-by":"publisher","award":["UL1TR002345"],"award-info":[{"award-number":["UL1TR002345"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"national cancer institute","doi-asserted-by":"publisher","award":["P50 CA-244431"],"award-info":[{"award-number":["P50 CA-244431"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>Evidence-based practice for stroke prevention in high-income countries involves screening for abnormal transcranial Doppler (TCD) velocity and initiating regular blood transfusions for at least 1\u00a0year, followed by treatment with hydroxyurea. This practice has not been transferred to low-resource settings like Nigeria, the country with the highest global population density of SCD. Following a multi-center randomized controlled trial among children with SCA in northern Nigeria, screening for stroke and initiation of hydroxyurea was established as standard of care at the clinical trial sites and other locations. We aim to describe the critical steps we took in translating research into practice for stroke prevention in SCA in Nigeria. Guided by the PRISM framework, we describe how we translated results from a randomized controlled trial for primary prevention of stroke in children with sickle cell anemia into usual care for children with SCA in Kaduna, Nigeria.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Findings from this study demonstrate the importance of organizational support and stakeholder involvement from the onset of a clinical trial. Having the dual objective of conducting an efficacy trial while simultaneously focusing on strategies for future implementation can significantly decrease the lag time between discovery and routine practice.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13104-021-05885-1","type":"journal-article","created":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T11:05:09Z","timestamp":1641294309000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Translating research to usual care of children with sickle cell disease in Northern Nigeria: lessons learned from the SPRING Trial Team"],"prefix":"10.1186","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9993-4548","authenticated-orcid":false,"given":"Halima","family":"Bello-Manga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawal","family":"Haliru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulkadir M.","family":"Tabari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bilkisu","family":"Farouk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aisha","family":"Suleiman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria Y.","family":"Bahago","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulrasheed M.","family":"Sani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana A.","family":"Bauman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael R.","family":"DeBaun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison A.","family":"King","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,4]]},"reference":[{"issue":"1","key":"5885_CR1","first-page":"288","volume":"91","author":"K Ohene-Frempong","year":"1998","unstructured":"Ohene-Frempong K, Weiner SJ, Sleeper LA, Miller ST, Embury S, Moohr JW, Wethers DL, Pegelow CH, Gill FM. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood. 1998;91(1):288\u201394.","journal-title":"Blood"},{"issue":"10019","key":"5885_CR2","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/S0140-6736(15)01041-7","volume":"387","author":"RE Ware","year":"2016","unstructured":"Ware RE, Davis BR, Schultz WH, Brown RC, Aygun B, Sarnaik S, Odame I, Fuh B, George A, Owen W, et al. Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial. Lancet. 2016;387(10019):661\u201370.","journal-title":"Lancet"},{"issue":"1","key":"5885_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1056\/NEJM199807023390102","volume":"339","author":"RJ Adams","year":"1998","unstructured":"Adams RJ, McKie VC, Hsu L, Files B, Vichinsky E, Pegelow C, Abboud M, Gallagher D, Kutlar A, Nichols FT, et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med. 1998;339(1):5\u201311.","journal-title":"N Engl J Med"},{"issue":"7","key":"5885_CR4","doi-asserted-by":"publisher","first-page":"e1001484","DOI":"10.1371\/journal.pmed.1001484","volume":"10","author":"FB Piel","year":"2013","unstructured":"Piel FB, Hay SI, Gupta S, Weatherall DJ, Williams TN. Global burden of sickle cell anaemia in children under five, 2010\u20132050: modelling based on demographics, excess mortality, and interventions. PLoS Med. 2013;10(7):e1001484.","journal-title":"PLoS Med"},{"issue":"3","key":"5885_CR5","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s40609-018-0121-0","volume":"6","author":"AA Baumann","year":"2019","unstructured":"Baumann AA, Mejia A, Lachman JM, Parra-Cardona R, L\u00f3pez-Zer\u00f3n G, Buenabad NGA, Contreras EV, Rodr\u00edguez MMD. Parenting programs for underserved populations in low-and middle-income countries: issues of scientific integrity and social justice. Glob Soc Welf. 2019;6(3):199\u2013207.","journal-title":"Glob Soc Welf"},{"issue":"4","key":"5885_CR6","first-page":"228","volume":"34","author":"AC Feldstein","year":"2008","unstructured":"Feldstein AC, Glasgow RE. A practical, robust implementation and sustainability model (PRISM) for integrating research findings into practice. Jt Comm J Qual Patient Saf. 2008;34(4):228\u201343.","journal-title":"Jt Comm J Qual Patient Saf"},{"issue":"1","key":"5885_CR7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1093\/inthealth\/iht022","volume":"6","author":"N Galadanci","year":"2014","unstructured":"Galadanci N, Wudil BJ, Balogun TM, Ogunrinde GO, Akinsulie A, Hasan-Hanga F, Mohammed AS, Kehinde MO, Olaniyi JA, Diaku-Akinwumi IN, et al. Current sickle cell disease management practices in Nigeria. Int Health. 2014;6(1):23\u20138.","journal-title":"Int Health"},{"issue":"8","key":"5885_CR8","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1002\/ajh.24770","volume":"92","author":"NA Galadanci","year":"2017","unstructured":"Galadanci NA, Umar Abdullahi S, Vance LD, Musa Tabari A, Ali S, Belonwu R, Salihu A, Amal Galadanci A, Wudil Jibir B, Bello-Manga H, et al. Feasibility trial for primary stroke prevention in children with sickle cell anemia in Nigeria (SPIN trial). Am J Hematol. 2017;92(8):780\u20138.","journal-title":"Am J Hematol"},{"issue":"8","key":"5885_CR9","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1182\/bloodadvances.2019001142","volume":"4","author":"MR DeBaun","year":"2020","unstructured":"DeBaun MR, Jordan LC, King AA, Schatz J, Vichinsky E, Fox CK, McKinstry RC, Telfer P, Kraut MA, Daraz L, et al. American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults. Blood Adv. 2020;4(8):1554\u201388.","journal-title":"Blood Adv"},{"key":"5885_CR10","doi-asserted-by":"publisher","first-page":"112585","DOI":"10.1016\/j.psychres.2019.112585","volume":"283","author":"MM McKay","year":"2020","unstructured":"McKay MM, Sensoy Bahar O, Ssewamala FM. Implementation science in global health settings: collaborating with governmental & community partners in Uganda. Psychiatry Res. 2020;283:112585.","journal-title":"Psychiatry Res"},{"issue":"6","key":"5885_CR11","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1093\/tbm\/ibz085","volume":"9","author":"MS McCreight","year":"2019","unstructured":"McCreight MS, Rabin BA, Glasgow RE, Ayele RA, Leonard CA, Gilmartin HM, Frank JW, Hess PL, Burke RE, Battaglia CT. Using the Practical, Robust Implementation and Sustainability Model (PRISM) to qualitatively assess multilevel contextual factors to help plan, implement, evaluate, and disseminate health services programs. Transl Behav Med. 2019;9(6):1002\u201311.","journal-title":"Transl Behav Med"},{"key":"5885_CR12","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1146\/annurev-publhealth-040617-014731","volume":"39","author":"RC Shelton","year":"2018","unstructured":"Shelton RC, Cooper BR, Stirman SW. The sustainability of evidence-based interventions and practices in public health and health care. Annu Rev Public Health. 2018;39:55\u201376.","journal-title":"Annu Rev Public Health"},{"key":"5885_CR13","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/1748-5908-8-117","volume":"8","author":"DA Chambers","year":"2013","unstructured":"Chambers DA, Glasgow RE, Stange KC. The dynamic sustainability framework: addressing the paradox of sustainment amid ongoing change. Implement Sci. 2013;8:117.","journal-title":"Implement Sci"},{"key":"5885_CR14","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1748-5908-7-32","volume":"7","author":"GA Aarons","year":"2012","unstructured":"Aarons GA, Green AE, Palinkas LA, Self-Brown S, Whitaker DJ, Lutzker JR, Silovsky JF, Hecht DB, Chaffin MJ. Dynamic adaptation process to implement an evidence-based child maltreatment intervention. Implement Sci. 2012;7:32.","journal-title":"Implement Sci"},{"key":"5885_CR15","doi-asserted-by":"publisher","first-page":"112376","DOI":"10.1016\/j.psychres.2019.04.025","volume":"283","author":"MS Bauer","year":"2019","unstructured":"Bauer MS, Kirchner J. Implementation science: what is it and why should I care? Psychiatry Res. 2019;283:112376.","journal-title":"Psychiatry Res"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-021-05885-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13104-021-05885-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-021-05885-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T23:05:24Z","timestamp":1641337524000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-021-05885-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,4]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["5885"],"URL":"https:\/\/doi.org\/10.1186\/s13104-021-05885-1","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,4]]},"assertion":[{"value":"11 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants that participated in the SPRING trial signed the informed consent\/assent. Ethical approval for the reported study was obtained from the Barau Dikko Teaching Hospital Health Research Ethics Committee and the National Health Research Ethics Committee of the Federal Ministry of Health.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1"}}